Dutch life sciences venture capital firm Forbion has raised over €2 billion across two new funds: Forbion Growth Opportunities III and Forbion Ventures VII, bringing the firm’s total assets under management to €5 billion. Both funds exceeded their initial targets, securing €1.2 billion and €890 million, respectively.